πŸ‡ΊπŸ‡Έ FDA
Patent

US 9499568

Heterocyclic compound and use thereof

granted A61PA61P25/00A61P25/14

Quick answer

US patent 9499568 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/18, A61P25/20